Rafinlar 75mg Capsule
Prescription Required
Product introduction
Rafinlar 75mg Capsule is used in the treatment of malignant melanoma, a type of skin cancer. It may also be used to treat other conditions as determined by the doctor.
Rafinlar 75mg Capsule
Rafinlar 75mg Capsule
Uses of Rafinlar Capsule
Benefits of Rafinlar Capsule
In Treatment of Malignant melanoma
Malignant melanoma is a type of skin cancer that develops in melanocytes, the cells that produce the pigment called melanin. Melanin is the pigment that gives the skin its color. Malignant melanoma is the most deadly and aggressive kind of skin cancer. Rafinlar 75mg Capsule sticks to the genetic code, called DNA, of the cancer cells and kills them. It also prevents their growth and further spread, which help treat cancer.
Side effects of Rafinlar Capsule
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if youβre worried about them
Common side effects of Rafinlar
- Diarrhea
- Fever
- Nausea
- Chills
- Headache
- Joint pain
- Cough
- Muscle pain
- Swelling
How to use Rafinlar Capsule
Take this medicine in the dose and duration as advised by your doctor. Rafinlar 75mg Capsule is to be taken empty stomach.
How Rafinlar Capsule works
Rafinlar 75mg Capsule is an anti-cancer medication. It works by blocking the activity of BRAF, a mutated protein that regulates cell growth. A BRAF mutation enables cells to divide at abnormal rate and grow into a melanoma tumor.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Rafinlar 75mg Capsule. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Rafinlar 75mg Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Rafinlar 75mg Capsule is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
UNSAFE
Rafinlar 75mg Capsule may cause side effects which could affect your ability to drive.
Kidney
SAFE IF PRESCRIBED
Rafinlar 75mg Capsule is safe to use in patients with kidney disease. No dose adjustment of Rafinlar 75mg Capsule is recommended.
Liver
SAFE IF PRESCRIBED
Rafinlar 75mg Capsule is safe to use in patients with liver disease. No dose adjustment of Rafinlar 75mg Capsule is recommended.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- Rafinlar 75mg Capsule is used alone or in combination with other medicines to treat a type of skin cancer called melanoma.
- Take it on an empty stomach, at least 1 hour before or 2 hours after a meal.
- Do not drive or do anything requiring concentration until you know how it affects you.
- Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine and for 4 months after you stop taking it.
- Inform your doctor if you get headaches, stomach pain or if you notice blood in your urine or stools.
- Get regular eye examinations while taking this medicine. Inform your doctor if you get eye irritation, blurred vision, eye pain or other vision changes during your treatment.
- Inform your doctor if you develop symptoms of liver damage such as abdominal pain, loss of appetite, darkened urine or yellowing of the eyes or skin.
Fact Box
Chemical Class
Sulfanilide Derivative
Habit Forming
No
Action Class
BRAF inhibitor
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Dabrafenib mesilate. Surrey, UK: Novartis Europharm Limited; 2013 [revised 20 Feb. 2019]. [Accessed 26 Mar. 2019] (online) Available from:
- Dabrafenib. East Hanover, New Jersey: Novartis Pharmaceuticals; 2013 [revised Jun. 2017]. [Accessed 26 Mar. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 27 Mar. 2019] (online) Available from:
Marketer details
Name: Novartis India Ltd
Address: Sandoz House, Shiv Sagar Estate, Worli Mumbai -400 018, India
Country of origin: United kingdom
Lab tests offered by us
Related/Popular tests
MRP
βΉ42450
Inclusive of all taxes
28.0 capsules in 1 bottle
SOLD OUT
Notify me